Introduction
============

Pain management has been a priority for prehospital and hospital care, and a variety of guidelines have been adopted accordingly ([@B1]). Existence of moderate to severe pain is one of the most important factors, which alternates patients' conditions and might have a negative impact on their physiological parameters, which could eventually worsen the patient's prognosis ([@B2], [@B3]). Pharmacological treatment choices in prehospital pain management are quite limited, considering that in prehospital care, analgesics should not only be effective and safe, but also not interfere with patients' transfer ([@B1]).

Based on literature reviews done in recent years and different expert panels conducted, several guidelines have been proposed for pain management in prehospital care ([@B4]-[@B6]). These guidelines suggest different treatment options varying from injectable opioids to intranasal non-opioid treatments. Nevertheless, instructions given by these protocols are usually taken from moderate to low quality studies ([@B7]), thus, there is no consensus over a single guideline. On the other hand, the majority of these guidelines only refer to a single disease or complication. In these instructions a broad range of analgesic drugs are proposed. Some of the guidelines suggest using multiple drugs instead of a single medication; and some others suggest using opioids in lower doses ([@B4]-[@B8]).

Clearly, there is not a consensus over establishing standard instructions on pre-hospital pain control. Hence, the present systematic review aims to collect and summarize pre-hospital pain management guidelines and instructions by conducting an extensive research in databases.

Method:
=======

**Study design and search strategy**

The current study is an umbrella review, which investigates the guidelines and protocols for pre-hospital pain management. The researchers conducted a comprehensive search in electronic databases. Appropriate keywords were defined to accomplish the study's objectives. For this purpose, "pre-hospital emergencies" and "analgesia" related words were obtained with advice of an experienced researcher in the field. Additionally, MeSh and Emtree word trees were investigated. The attained keywords were properly combined, and standard tags were adapted for each database. Subsequently, a comprehensive search was conducted in electronic databases including: Medline, Embase, Trip Medical Database and Scopus through March 2019. Search strategy in Medline database is presented in [Panel 1](#T1){ref-type="table"}. In addition to systematic search, manual search was also performed in Google search engine, Google scholar and references of relevant articles.

**Selection criteria**

In the present study, guidelines and protocols concerning pre-hospital pain management, published in peer-review journals or released in valid organizations' websites, were included. Reviews being narrative, lack of a report on the complete process of the guideline's extraction, and lack of a report on the systematic review's process were considered as exclusion criteria.

**Data collection and quality assessment**

The data collected from databases were saved in Endnote. Two independent researchers studied the records and screened titles and abstracts of relevant guidelines. After studying the full text of these guidelines, data were filed in a checklist created in Microsoft Excel. Obtained results were perused by the two researchers with the presence of a third researcher. Any disagreement was discussed and resolved.

Recorded data in the checklist consisted of name of the guideline, year of publication, studied medications, quality control and patients' conditions (trauma, etc.). In cases of non-extractable data in the articles, their authors were contacted. If the author did not respond to the first email, a reminder was sent. In case of no response, second reminder email was sent within two weeks. Granted that still no response was received, the other authors were contacted via social media such as ResearchGate and LinkedIn to attain required data.

###### 

Search query in medline

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Search terms
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1- "Emergency Medical Services"\[mh\] OR "Emergency Health Service"\[tiab\] OR "Emergency Care"\[tiab\] OR "Prehospital Medication"\[tiab\] OR "Prehospital Care"\[tiab\] OR "Prehospital"\[tiab\] OR "Emergency Services, Medical"\[tiab\] OR "Emergency Service, Medical"\[tiab\] OR "Medical Emergency Service"\[tiab\] OR "Medical Emergency Services"\[tiab\] OR "Service, Medical Emergency"\[tiab\] OR "Services, Medical Emergency"\[tiab\] OR "Medical Services, Emergency"\[tiab\] OR "Emergency Medical Service"\[tiab\] OR "Medical Service, Emergency"\[tiab\] OR "Service, Emergency Medical"\[tiab\] OR "Services, Emergency Medical"\[tiab\] OR "Prehospital Emergency Care"\[tiab\] OR "Emergency Care, Prehospital"\[tiab\] OR "Emergicenters"\[tiab\] OR "Emergicenter"\[tiab\] OR "Emergency Care"\[tiab\] OR "Emergency Health Services"\[tiab\] OR "Emergency Health Service"\[tiab\] OR "Health Service, Emergency"\[tiab\] OR "Health Services, Emergency"\[tiab\] OR "Service, Emergency Health"\[tiab\] OR "Services, Emergency Health"\[tiab\]\
  2- Patient Controlled Analgesia\[tiab\] OR Analgesic Drugs\[tiab\] OR Drugs, Analgesic\[tiab\] OR Anodynes\[tiab\] OR Analgesic Agents\[tiab\] OR Agents, Analgesic\[tiab\] OR Analgesics, Non Narcotic\[tiab\] OR Non-Narcotic Analgesics\[tiab\] OR Nonopioid Analgesics\[tiab\] OR Analgesics, Nonopioid\[tiab\] OR Non-Opioid Analgesics\[tiab\] OR Analgesics, Non-Opioid\[tiab\] OR Non Opioid Analgesics\[tiab\] OR Analgesics, Nonnarcotic\[tiab\] OR Nonnarcotic Analgesics\[tiab\] OR Antinociceptive Agents\[tiab\] OR Opioid Analgesics\[tiab\] OR Opioids\[tiab\] OR Partial Opioid Agonists\[tiab\] OR Agonists, Partial Opioid\[tiab\] OR Opioid Agonists, Partial\[tiab\] OR Opioid Partial Agonists\[tiab\] OR Agonists, Opioid Partial\[tiab\] OR Partial Agonists, Opioid\[tiab\] OR Full Opioid Agonists\[tiab\] OR Agonists, Full Opioid\[tiab\] OR Opioid Agonists, Full\[tiab\] OR Opioid Full Agonists\[tiab\] OR Agonists, Opioid Full\[tiab\] OR Full Agonists, Opioid\[tiab\] OR Opioid Mixed Agonist-Antagonists\[tiab\] OR Agonist-Antagonists, Opioid Mixed\[tiab\] OR Mixed Agonist-Antagonists, Opioid\[tiab\] OR Opioid Mixed Agonist Antagonists\[tiab\] OR Narcotic\[tiab\] OR Narcotic Analgesics\[tiab\] OR Analgesics, Narcotic\[tiab\] OR Narcotic Effect\[tiab\] OR Effect, Narcotic\[tiab\] OR Narcotic Effects\[tiab\] OR Effects, Narcotic\[tiab\] OR Antiinflammatory Agents, Non Steroidal\[tiab\] OR NSAIDs\[tiab\] OR Non-Steroidal Anti-Inflammatory Agents\[tiab\] OR Non Steroidal Anti Inflammatory Agents\[tiab\] OR Nonsteroidal Anti-Inflammatory Agents\[tiab\] OR Nonsteroidal Anti Inflammatory Agents\[tiab\] OR Anti Inflammatory Agents, Nonsteroidal\[tiab\] OR Antiinflammatory Agents, Nonsteroidal\[tiab\] OR Nonsteroidal Antiinflammatory Agents\[tiab\] OR Analgesics, Anti-Inflammatory\[tiab\] OR Anti-Inflammatory Analgesics\[tiab\] OR Aspirin-Like Agents\[tiab\] OR Aspirin Like Agents\[tiab\] OR Anesthetic Drugs\[tiab\] OR Drugs, Anesthetic\[tiab\] OR Anesthetic Agents\[tiab\] OR Agents, Anesthetic\[tiab\] OR Anesthetic Effect\[tiab\] OR Effect, Anesthetic\[tiab\] OR Anesthetic Effects\[tiab\] OR Effects, Anesthetic\[tiab\] OR Morphinan\[tiab\] OR "Acetaminophen"\[mh\] OR "Adapalene"\[mh\] OR "Adapalene, Benzoyl Peroxide Drug Combination"\[mh\] OR "Amantadine"\[mh\] OR "Amitriptyline"\[mh\] OR "Ampyrone"\[mh\] OR "Antipyrine"\[mh\] OR "Apazone"\[mh\] OR "Aspirin"\[mh\] OR "Bufexamac"\[mh\] OR "Carbachol"\[mh\] OR "Carbamazepine"\[mh\] OR "Celecoxib"\[mh\] OR "Clonixin"\[mh\] OR "Dexmedetomidine"\[mh\] OR "Diclofenac"\[mh\] OR "Diflunisal"\[mh\] OR "Dihydroergotamine"\[mh\] OR "Dipyrone"\[mh\] OR "Dronabinol"\[mh\] OR "Epirizole"\[mh\] OR "Ergotamine"\[mh\] OR "Etanercept"\[mh\] OR "Etodolac"\[mh\] OR "Etoricoxib"\[mh\] OR "Fenoprofen"\[mh\] OR "Feprazone"\[mh\] OR "Flurbiprofen"\[mh\] OR "Glafenine"\[mh\] OR "Ibuprofen"\[mh\] OR "Indomethacin"\[mh\] OR "Indoprofen"\[mh\] OR "Interleukin-2"\[mh\] OR "Ketoprofen"\[mh\] OR "Ketorolac"\[mh\] OR "Ketorolac Tromethamine"\[mh\] OR "Masoprocol"\[mh\] OR "Meclofenamic Acid"\[mh\] OR "Medetomidine"\[mh\] OR "Mefenamic Acid"\[mh\] OR "Meloxicam"\[mh\] OR "Mesalamine"\[mh\] OR "Methotrimeprazine"\[mh\] OR "Milnacipran"\[mh\] OR "Nabumetone"\[mh\] OR "Naproxen"\[mh\] OR "Nefopam"\[mh\] OR "Niflumic Acid"\[mh\] OR "Nitrous Oxide"\[mh\] OR "Olopatadine Hydrochloride"\[mh\] OR "Oxaprozin"\[mh\] OR "Oxyphenbutazone"\[mh\] OR "Phenacetin"\[mh\] OR "Phenylbutazone"\[mh\] OR "Piroxicam"\[mh\] OR "Pizotyline"\[mh\] OR "Quinine"\[mh\] OR "Resveratrol"\[mh\] OR "Salicylates"\[mh\] OR "Sodium Salicylate"\[mh\] OR "Sulfasalazine"\[mh\] OR "Sulindac"\[mh\] OR "Suprofen"\[mh\] OR "Tolmetin"\[mh\] OR "Alfentanil"\[mh\] OR "Alphaprodine"\[mh\] OR "Buprenorphine"\[mh\] OR "Buprenorphine, Naloxone Drug Combination"\[mh\] OR "Butorphanol"\[mh\] OR "Dextromoramide"\[mh\] OR "Dextropropoxyphene"\[mh\] OR "Dihydromorphine"\[mh\] OR "Diphenoxylate"\[mh\] OR "Ethylketocyclazocine"\[mh\] OR "Ethylmorphine"\[mh\] OR "Etorphine"\[mh\] OR "Fentanyl"\[mh\] OR "Hydrocodone"\[mh\] OR "Hydromorphone"\[mh\] OR "Levorphanol"\[mh\] OR "Meperidine"\[mh\] OR "Meptazinol"\[mh\] OR "Methadone"\[mh\] OR "Nalbuphine"\[mh\] OR "Opiate Alkaloids"\[mh\] OR "Opium"\[mh\] OR "Oxycodone"\[mh\] OR "Oxymorphone"\[mh\] OR "Pentazocine"\[mh\] OR "Phenazocine"\[mh\] OR "Phenoperidine"\[mh\] OR "Pirinitramide"\[mh\] OR "Promedol"\[mh\] OR "Remifentanil"\[mh\] OR "Sufentanil"\[mh\] OR "Tapentadol"\[mh\] OR "Tilidine"\[mh\] OR "Tramadol"\[mh\]\
  3- \#1 AND \#2

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

The characteristics of included guidelines

  **Name of guideline**                                                                               **Update date**   **Target patients**                **Age group**        **Organization**                                           **Level of evidence**   **Reference**
  --------------------------------------------------------------------------------------------------- ----------------- ---------------------------------- -------------------- ---------------------------------------------------------- ----------------------- ---------------
  Netherlands Association for Emergency Nurses (NAEN) Guideline                                       2014              Trauma patients                    Adults               Netherlands Association for Emergency Nurses               Moderate                ([@B22])
  Alabama Department of Public Health EMS (ADPH-EMS) Protocol                                         2018              Patients with severe pain          Adults; Pediatrics   Alabama State Emergency Medical Control Committee          Moderate                ([@B11])
  Douglas County Fire/EMS (Emergency Medical Services)(DCFEMS) Guideline                              2017              Trauma patients with severe pain   Adults; Pediatrics   Douglas County Fire/EMS (Emergency Medical Services)       Moderate                ([@B12])
  Ambulance Tasmania Clinical Practice (ATCP) Guidelines for Paramedics & Intensive Care Paramedics   2012              General pain management            Adults; Pediatrics   Ambulance Tasmania                                         High to moderate        ([@B13])
  North Carolina College of Emergency Physicians (NCCEP) Protocol                                     2019              General pain management            Adults; Pediatrics   North Carolina College of Emergency Physicians             High to moderate        ([@B14])
  Clinical Practice Guideline of Pre-Hospital Emergency Care Council (PHECC)                          2018              General pain management            Adults; Pediatrics   Pre-Hospital Emergency Care Council                        Moderate                ([@B15])
  Ambulance Victoria Clinical Practice (AVCP) Guideline                                               2018              General pain management            Adults; Pediatrics   Australia Ambulance Victoria                               High to moderate        ([@B16])
  Maryland Institute for Emergency Medical Services System (MIEMS) Guideline                          2014              General pain management            Adults; Pediatrics   Maryland Institute for Emergency Medical Services System   Moderate                ([@B7])
  Italian Intersociety Recommendations on pain management (IIRPM) in the emergency setting            2015              General pain management            Adults; Pediatrics   Italian Intersociety Recommendations on pain management    High to moderate        ([@B18])
  New Mexico Pre-hospital Treatment (NMPHT) Guideline                                                 2018              General pain management            Adults; Pediatrics   New Mexico Department of Health                            Moderate                ([@B19])
  U.S National Association of EMS Physicians (NAEMSP) guideline                                       2014              Trauma patients                    Adults; Pediatrics   U.S NAEMSP Medical Directors Council                       High to moderate        ([@B20])
  UK National Institute for Health and Care Excellence (NICE) guideline                               2016              Trauma patients                    Adults               UK National Institute for Health and Care Excellence       High to moderate        ([@B21])

###### 

Recommendations for pre-hospital pain management in adults

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Guideline**        **Pain severity**    **Morphine**                                                                                                                              **Fentanyl**                                                                                                                    **Ketamine**                                                                                   **Paracetamol**
  -------------------- -------------------- ----------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------
  **NAEN, 2014**       Moderate             \--                                                                                                                                       1-2 μg/kg every 3 mins (titrate medication on effect)                                                                           If hypovolemia or shock state is present 0.25 mg/kg+ Midazolam 1 mg                            1000 mg IV for 5 min or 1000 mg oral

                       Severe               \--                                                                                                                                       1-2 μg/kg every 3 mins (titrate medication on effect)                                                                           If hypovolemia or shock state is present 0.25 mg/kg+ Midazolam 1 mg                            1000 mg IV for 5 min titrate until NRS\<4

  **ADPH-EMS, 2018**   Severe               4 mg initial dose, titrate to pain relief in 2 mg every 3-5 mins, to an initial maximum dose of 10 mg cumulative maximum dose of 25 mg\   1 μg/kg slow IV/IM/IN to an initial maximum dose of 50 μg. May repeat once.                                                     0.2 mg slow IV to a maximum dose of 25 mg\                                                     \--
                                            **OR**\                                                                                                                                                                                                                                                                   **OR**\                                                                                        
                                            0.5 mg IM and cumulative maximum dose of 50 mg                                                                                                                                                                                                                            0.5 mg IM to a maximum dose of 50 mg                                                           

  **DCFEMS, 2017**     Severe               2-4 mg IV/IO/IM slowly titrate to pain relief to a maximum dose of 10 mg every 10 mins                                                    25 μg IV/IO slowly OR 2 μg/kg IN, titrate to pain relief to a maximum dose of 100 μg every 10 mins                              \--                                                                                            \--

  **ATCP, 2012**       Mild                 \--                                                                                                                                       \--                                                                                                                             \--                                                                                            1000 mg

  **ATCP, 2012**       Moderate             Up to 0.05 mg/kg IV/IO (initial maximum dose of maximum 5 mg), titrate to pain relief to a maximum dose of 20 mg every 5 mins             Up to 0.5 μg/kg IV/IO (initial maximum dose of 5 mg), titrate to pain relief to a maximum dose of 200 μg every 5 mins\          \--                                                                                            1000 mg
                                                                                                                                                                                      **If the IV access \>10 mins delayed/unsuccessful**\                                                                                                                                                                           
                                                                                                                                                                                      up to 100 μg IN, titrate to pain relief to a maximum dose of 400 μg every 5 mins                                                                                                                                               

                       Severe               Up to 0.05 mg/kg IV/IO (initial maximum dose of maximum 5 mg), titrate to pain relief to a maximum dose of 20 mg every 5 mins             Up to 0.5 μg/kg IV/IO (initial maximum dose of maximum 5 mg), titrate to pain relief to a maximum dose of 200 μg every 5 mins   \--                                                                                            \--

  **NCCEP, 2019**      Mild                 \--                                                                                                                                       \--                                                                                                                             \--                                                                                            15 mg/kg oral

                       Moderate to severe   4 mg IV/IO/IM repeat 2 mg every 5 mins if required                                                                                        50-75 μg IV/IO repeat 25 μg every 20 mins to a maximum 200 μg                                                                   \--                                                                                            \--

  **PHECC, 2018**      Mild                 \--                                                                                                                                       \--                                                                                                                             \--                                                                                            1000 mg oral

                       Moderate             \--                                                                                                                                       \--                                                                                                                             \--                                                                                            1000 mg oral

                       Severe               4 mg IV, repeat 2 mg to pain relief to a maximum dose of 16 mg every 2 mins                                                               100 μg IN or 50 μg IV, repeat IN once only after 10 min if needed                                                               0.1 mg/kg IV, repeat once only after 10 min if needed                                          1000 mg IV

  **AVCP, 2018**       Mild                 \--                                                                                                                                       \--                                                                                                                             \--                                                                                            1000 mg oral;\
                                                                                                                                                                                                                                                                                                                                                                                                                     500 mg if weight \< 60 kg or frail or elderly, malnourished or liver disease

                       Moderate             Up to 5 mg IV, titrate to pain relief every 5 mins (consult after 20 mg)                                                                  Up to 50 μg IV, titrate to pain relief every 5 mins (consult after 200 μg)\                                                     \--                                                                                            \--
                                                                                                                                                                                      **OR**\                                                                                                                                                                                                                        
                                                                                                                                                                                      200 μg IN repeat up to 50 μg IN every 5 minutes (consult after 400 μg)                                                                                                                                                         

                       Severe               Up to 5 mg IV, titrate to pain relief every 5 mins (consult after 20 mg)\                                                                 Up to 50 μg IV, titrate to pain relief every 5 mins (consult after 200 μg)\                                                     Extreme traumatic pain persists to opioid:\                                                    \--
                                            **OR**\                                                                                                                                   **OR**\                                                                                                                         10-20 mg IV at 5-10 min intervals;\                                                            
                                            10 mg IM, repeat 5 mg IM after 15 minutes once only if required                                                                           200 μg IN repeat up to 50 μg IN every 5 minutes (consult after 400 μg)                                                          For severe pain 20-30 mg IV at 2 minute interval                                               

  **MIEMS, 2014**      Moderate to severe   0.1 mg/kg IV/IO, repeat 0.05 mg/kg IV/IO to pain relief every 5 mins                                                                      1 μg/kg IV/IO, repeat 0.5 mg/kg IV/IO to pain relief every 5 mins                                                               \--                                                                                            \--

  **IIRPM, 2015**      Mild                 \--                                                                                                                                       \--                                                                                                                             \--                                                                                            1000 mg

                       Moderate             \--                                                                                                                                       \--                                                                                                                             \--                                                                                            1000 mg

                       Severe               4-6 mg IV;\                                                                                                                               50-100 μg IV                                                                                                                    \--                                                                                            \--
                                            2-3 mg for patients aged \>65 years and/or unstable patients                                                                                                                                                                                                                                                                                                             

  **NMPHT, 2018**      Moderate to severe   4-10 mg slow IV/IO, titrating 2-4 mg every 10 mins with a maximum dose of 10 mg                                                           25-100 μg IV/IO                                                                                                                 \--                                                                                            \--

  **NAEMSP, 2014**     Moderate             0.1 mg/kg IM to a maximum initial dose of 15 mg                                                                                           1 μg/kg IN/IM to a maximum dose of 100 μg                                                                                       0.5 mg/kg IN to a maximum initial dose of 25 mg and maximum cumulative dose of 100 mg          15 mg/kg oral to a maximum dose of 1000 mg

                       Severe               0.1 mg/kg IV/IO to a maximum dose of 10 mg                                                                                                1 μg/kg IV/IO to a maximum dose of 100 μg                                                                                       0.25 mg/kg IM/IV/IO to a maximum initial dose of 25 mg and maximum cumulative dose of 100 mg   \--

  **NICE, 2016**       Moderate to severe   Yes (IV first line; dosage not reported)                                                                                                  \--                                                                                                                             Yes Second line IN                                                                             \--
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Recommendations for pre-hospital pain management in adults (continue...)

  **Guideline**        **Pain severity**    **Midazolam**   **Nitric oxide**            **Ketorolac**                             **Ibuprofen**                               **Methoxyﬂurane**                              **NSAIDs**
  -------------------- -------------------- --------------- --------------------------- ----------------------------------------- ------------------------------------------- ---------------------------------------------- ----------------------------
  **NAEN, 2014**       Moderate             \--             \--                         \--                                       \--                                         \--                                            \--
                       Severe               \--             \--                         \--                                       \--                                         \--                                            \--
  **ADPH-EMS, 2018**   Severe               \--             Until pain control          \--                                       \--                                         \--                                            \--
  **DCFEMS, 2017**     Severe               \--             \--                         \--                                       \--                                         \--                                            \--
  **ATCP, 2012**       Mild                 \--             \--                         \--                                       \--                                         \--                                            \--
                       Moderate             \--             \--                         \--                                       \--                                         \--                                            \--
                       Severe               \--             \--                         \--                                       \--                                         3 ml (repeat 3 ml if required (maximum 6 ml)   \--
  **NCCEP, 2019**      Mild                 \--             \--                         \--                                       \--                                         \--                                            \--
                       Moderate to severe   \--             \--                         \--                                       10 mg/kg oral                               \--                                            \--
  **PHECC, 2018**      Mild                 \--             50:50 mix                   30 mg IV/IO OR 60 mg IM (Maximum 60 mg)   \--                                         \--                                            \--
                       Moderate             \--             \--                         \--                                       400 mg oral                                 \--                                            \--
                       Severe               \--             50:50 mix                   \--                                       600 mg oral                                 3 ml, repeat once only if needed               \--
  **AVCP, 2018**       Mild                 \--             \--                         \--                                       \--                                         \--                                            \--
                       Moderate             \--             \--                         \--                                       \--                                         \--                                            \--
                       Severe               \--             \--                         \--                                       \--                                         3 ml (repeat 3 ml if required (maximum 6 ml)   \--
  **MIEMS, 2014**      Moderate to severe   \--             \--                         \--                                       \--                                         \--                                            \--
  **IIRPM, 2015**      Mild                 \--             \--                         \--                                       \--                                         \--                                            \--
                       Moderate             \--             \--                         \--                                       \--                                         \--                                            Yes (dosage not reported)
  **IIRPM, 2015**      Severe               \--             \--                         \--                                       \--                                         \--                                            Yes (dosage not reported)
  **NMPHT, 2018**      Moderate to severe   \--             \--                         \--                                       \--                                         \--                                            \--
  **NAEMSP, 2014**     Moderate             \--             \--                         \--                                       \--                                         \--                                            Contraindication in trauma
                       Severe               \--             Yes (dosage not reported)   30 mg IM once only                        10 mg/kg oral to a maximum dose of 800 mg   \--                                            \--
  **NICE, 2016**       Moderate to severe   \--             \--                         15 mg IV once only                        \--                                         \--                                            \--

###### 

Recommendations for pre-hospital pain management in adults (continue...)

  **Guideline**                **Pain severity**    **Codeine**   **Tramadol**   **hydromorphone**   **diamorphine**             **Aspirin**
  ---------------------------- -------------------- ------------- -------------- ------------------- --------------------------- -----------------
  **NAEN, 2014**               Moderate             \--           \--            \--                 \--                         \--
                               Severe               \--           \--            \--                 \--                         \--
  **ADPH-EMS, 2018**           Severe               \--           \--            \--                 \--                         \--
  **DCFEMS, 2017**             Severe               \--           \--            \--                 \--                         \--
  **ATCP, 2012**               Mild                 \--           \--            \--                 \--                         \--
                               Moderate             \--           \--            \--                 \--                         \--
                               Severe               \--           \--            \--                 \--                         \--
  **NCCEP, 2019**              Mild                 \--           \--            \--                 \--                         \--
                               Moderate to severe   \--           \--            \--                 \--                         324-650 mg oral
  **PHECC, 2018**              Mild                 \--           \--            \--                 \--                         \--
                               Moderate             \--           \--            \--                 \--                         \--
                               Severe               \--           \--            \--                 \--                         \--
  **AVCP, 2018**               Mild                 \--           \--            \--                 \--                         \--
                               Moderate             \--           \--            \--                 \--                         \--
                               Severe               \--           \--            \--                 \--                         \--
  **MIEMS, 2014**              Moderate to severe   \--           \--            \--                 \--                         \--
  **IIRPM, 2015**              Mild                 \--           \--            \--                 \--                         \--
                               Moderate             \--           \--            \--                 \--                         \--
  **IIRPM, 2015**              Severe               30 mg oral    37.5 mg oral   \--                 \--                         \--
  **NMPHT, 2018**              Moderate to severe   \--           \--            \--                 \--                         \--
  **NAEMSP guideline, 2014**   Moderate             \--           \--            \--                 \--                         \--
                               Severe               \--           \--            \--                 \--                         \--
  **NICE, 2016**               Moderate to severe   \--           \--            \--                 Yes (dosage not reported)   \--
                               Mild to moderate     \--           \--            \--                 \--                         \--

###### 

Recommendations for pre-hospital pain management in children

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Guideline**        **Pain severity**    **Morphine**                                                                                                         **Fentanyl**                                                                                                              **Ketamine**                                                                                   **Paracetamol**
  -------------------- -------------------- -------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- --------------------------------------------
  **ADPH-EMS, 2018**   Severe               0.1 mg slow IV to a maximum dose of 5 mg                                                                             1 μg/kg slow IV/IN to a maximum dose of 50 μg                                                                             0.2 mg slow IV to a maximum dose of 25 mg\                                                     \--
                                                                                                                                                                                                                                                                                           **OR**\                                                                                        
                                                                                                                                                                                                                                                                                           0.5 mg IM to maximum dose of 50 mg\                                                            
                                                                                                                                                                                                                                                                                           **OR**\                                                                                        
                                                                                                                                                                                                                                                                                           1 mg/kg IN to a maximum dose of 50 mg                                                          

  **DCFEMS, 2017**     Severe               \--                                                                                                                  1-2 μg/kg IV/IO slowly or 1-2 μg/kg IN\                                                                                   \--                                                                                            \--
                                                                                                                                                                 Titrate to pain relief to a maximum dose of 100 μg every 10 mins                                                                                                                                                         

  **ATCP, 2012**       Mild                 \--                                                                                                                  \--                                                                                                                       \--                                                                                            15 mg/kg oral

                       Moderate             \--                                                                                                                  25 μg IN for small child (10-24 kg)\                                                                                      \--                                                                                            15 mg/kg oral
                                                                                                                                                                 50 μg for large child (\>=25 kg)\                                                                                                                                                                                        
                                                                                                                                                                 Titrate initial IN dose to pain relief (maximum 3 doses) every 5 mins                                                                                                                                                    

  **ATCP, 2012**       Severe               **Last resort if pain not controlled**\                                                                              25 μg IN for small child (10-24 kg)\                                                                                      \--                                                                                            \--
                                            Up to 0.1 mg/kg IM (maximum dose of 5 mg), single dose only\                                                         50 μg for large child (\>=25 kg)\                                                                                                                                                                                        
                                            **OR**\                                                                                                              Titrate initial IN dose to pain relief (maximum 3 doses) every 5 mins;\                                                                                                                                                  
                                            Up to 0.05 mg/kg IV, titrate to pain relief to a maximum dose of 0.2 mg/kg every 5 mins                              If pain not controlled up to 0.5 μg/kg IV, repeat a single dose to pain relief to a maximum dose of 2 μg/kg after 5 min                                                                                                  

  **NCCEP, 2019**      Moderate to severe   0.1 mg/kg IV/IO/IM repeat 0.1 mg/kg every 5 mins (maximum 10 mg)                                                     1 μg/kg IV/IO/IM/IN repeat 0.5 μg/kg every 5 mins (maximum 2 μg/kg)                                                       \--                                                                                            \--

  **PHECC, 2018**      Mild                 \--                                                                                                                  \--                                                                                                                       \--                                                                                            20 mg/kg oral

                       Moderate             \--                                                                                                                  \--                                                                                                                       \--                                                                                            20 mg/kg oral

                       Severe               0.3 mg/kg PO, for age\>=1 year old, repeat 0.1 mg/kg to pain relief to a maximum dose of 0.1 mg/kg IV every 2 mins   1.5 μg/kg IN, for age\>=1 year old, repeat IN once only after 10 min if needed                                            0.1 mg/kg IV, repeat once only after 10 min if needed                                          If age\<=1 years: 7.5 mg/kg IV\
                                                                                                                                                                                                                                                                                                                                                                                          If age\>1 years 15 mg/kg IV

  **AVCP, 2018**       Mild                 \--                                                                                                                  \--                                                                                                                       \--                                                                                            15 mg/kg oral

                       Moderate             \--                                                                                                                  25 μg IN for small child (10-24 kg)\                                                                                      \--                                                                                            15 mg/kg oral
                                                                                                                                                                 25 to 50 μg IN for medium child (18 to 39 kg)\                                                                                                                                                                           
                                                                                                                                                                 Repeat 3 doses if needed (consult after 3 doses)                                                                                                                                                                         

  **AVCP, 2018**       Severe               0.05 to 0.1 mg/kg IV, titrate to pain relief to a maximum dose of 0.2 mg/kg every 5-10 mins                          25 μg IN for small child (10-24 kg)\                                                                                      **Extreme traumatic pain persists despite opioid prescription**\                               \--
                                                                                                                                                                 25 to 50 mg IN for medium child (18 to 39 kg)\                                                                            0.25 mg/kg IV at 5-10 min intervals (maximum 0.5 mg/kg)                                        
                                                                                                                                                                 Repeat 3 doses if needed (consult after 3 doses)                                                                                                                                                                         

  **MIEMS, 2014**      Moderate to severe   0.1 mg/kg IV/IO, repeat 0.05 mg/kg IV/IO to pain relief every 5 mins                                                 1 μg/kg IV/IO, repeat 0.5 mg/kg IV/IO to pain relief every 5 mins                                                         \--                                                                                            \--

  **IIRPM, 2015**      Mild                 \--                                                                                                                  \--                                                                                                                       \--                                                                                            10-15 mg/kg oral

                       Moderate             \--                                                                                                                  \--                                                                                                                       \--                                                                                            15 mg/kg IV

                       Severe               0.05-0.1 mg/kg                                                                                                       1-2 μg/kg                                                                                                                 \--                                                                                            \--

  **NMPHT, 2018**      Moderate to severe   0.05 mg/kg IV/IO/IM                                                                                                  0.5 to 1 μg/kg IV/IO                                                                                                      \--                                                                                            \--

  **NAEMSP, 2014**     Moderate             0.1 mg/kg IM to a maximum initial dose of 15 mg                                                                      1 μg/kg IN/IM to a maximum dose of 100 μg                                                                                 0.5 mg/kg IN to a maximum initial dose of 25 mg and maximum cumulative dose of 100 mg          15 mg/kg oral to a maximum dose of 1000 mg

                       Severe               0.1 mg/kg IV/IO to a maximum dose of 10 mg                                                                           \--                                                                                                                       0.25 mg/kg IM/IV/IO to a maximum initial dose of 25 mg and maximum cumulative dose of 100 mg   \--
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Recommendations for pre-hospital pain management in children (continue...)

  **Guideline**    **Pain severity**    **Midazolam**   **Nitric oxide**                       **Ketorolac**                               **Ibuprofen**                               **Methoxyﬂurane**                                        **NSAIDs**
  ---------------- -------------------- --------------- -------------------------------------- ------------------------------------------- ------------------------------------------- -------------------------------------------------------- ----------------------------
  ADPH-EMS, 2018   Severe               \--             Consult with online medical director   \--                                         \--                                         \--                                                      \--
  DCFEMS, 2017     Severe               \--             \--                                    \--                                         \--                                         \--                                                      \--
                   Severe               \--             \--                                    \--                                         \--                                         \--                                                      \--
  ATCP, 2012       Mild                 \--             \--                                    \--                                         \--                                         \--                                                      \--
                   Moderate             \--             \--                                    \--                                         \--                                         3 ml (repeat 3 ml if required (maximum 6 ml)             \--
                   Severe               \--             \--                                    \--                                         \--                                         3 ml (repeat 3 ml if required (maximum 6 ml)             \--
  NCCEP, 2019      Moderate to severe   \--             \--                                    0.5 mg/kg IV/IO/IM (Maximum 30 mg)          \--                                         \--                                                      \--
  PHECC, 2018      Mild                 \--             \--                                    \--                                         10 mg/kg oral                               \--                                                      \--
                   Moderate             \--             50:50 mix                              \--                                         10 mg/kg oral                               3 ml, for age\>=5 years old repeat once only if needed   \--
                   Severe               \--             \--                                    \--                                         \--                                         \--                                                      \--
  AVCP, 2018       Mild                 \--             \--                                    \--                                         \--                                         \--                                                      \--
                   Moderate             \--             \--                                    \--                                         \--                                         3 ml (repeat 3 ml if required (maximum 6 ml)             \--
                   Severe               \--             \--                                    \--                                         \--                                         3 ml (repeat 3 ml if required (maximum 6 ml)             \--
  MIEMS, 2014      Moderate to severe   \--             \--                                    \--                                         \--                                         \--                                                      \--
  IIRPM, 2015      Mild                 \--             \--                                    \--                                         4-10 mg/kg oral                             \--                                                      \--
                   Moderate             \--             \--                                    \--                                         \--                                         \--                                                      \--
                   Severe               \--             \--                                    \--                                         \--                                         \--                                                      Contraindication in trauma
  NMPHT, 2018      Moderate to severe   \--             \--                                    \--                                         \--                                         \--                                                      \--
  NAEMSP, 2014     Moderate             \--             Yes (dosage not reported)              1 mg IM to a maximum dose of 30 mg          10 mg/kg oral to a maximum dose of 800 mg   \--                                                      \--
                   Severe               \--             \--                                    0.5 mg/kg IV with a maximum dose of 15 mg   \--                                         \--                                                      \--

###### 

Recommendations for pre-hospital pain management in children (continue...)

  **Guideline**        **Pain severity**    **Codeine**      **Tramadol**   **hydromorphone**                                                                             **diamorphine**   **Aspirin**
  -------------------- -------------------- ---------------- -------------- --------------------------------------------------------------------------------------------- ----------------- -------------
  **ADPH-EMS, 2018**   Severe               \--              \--            \--                                                                                           \--               \--
  **DCFEMS, 2017**     Severe               \--              \--            \--                                                                                           \--               \--
  **ATCP, 2012**       Mild                 \--              \--            \--                                                                                           \--               \--
                       Moderate             \--              \--            \--                                                                                           \--               \--
                       Severe               \--              \--            \--                                                                                           \--               \--
  **NCCEP, 2019**      Moderate to severe   \--              \--            \--                                                                                           \--               \--
  **PHECC, 2018**      Mild                 \--              \--            \--                                                                                           \--               \--
                       Moderate             \--              \--            \--                                                                                           \--               \--
                       Severe               \--              \--            \--                                                                                           \--               \--
  **AVCP, 2018**       Mild                 \--              \--            \--                                                                                           \--               \--
                       Moderate             \--              \--            \--                                                                                           \--               \--
                       Severe               \--              \--            \--                                                                                           \--               \--
  **MIEMS, 2014**      Moderate to severe   \--              \--            \--                                                                                           \--               \--
  **IIRPM, 2015**      Mild                 \--              \--            \--                                                                                           \--               \--
                       Moderate             1.5 mg/kg oral   1-2 mg/kg      \--                                                                                           \--               \--
                       Severe               \--              \--            \--                                                                                           \--               \--
  **NMPHT, 2018**      Moderate to severe   \--              \--            \--                                                                                           \--               \--
  **NAEMSP, 2014**     Moderate             \--              \--            \--                                                                                           \--               \--
                       Severe               \--              \--            0.015 mg/kg IM/IV/IO to an initial maximum dose of 2 mg and cumulative maximum dose of 4 mg   \--               \--

###### 

Quality assessment of prehospital pain management guidelines based on AGREE II recommendation

  **Guideline**    **Quality score (%)**   **Overall Quality score**   **Vote to recommend use**                                  
  ---------------- ----------------------- --------------------------- --------------------------- ----- ----- ---- ----- --- --- ---
  NAEN, 2014       100                     100                         29                          100   96    33   4.5   1   1   0
  ADPH-EMS, 2018   100                     94                          25                          100   79    50   6.0   2   0   0
  DCFEMS, 2017     100                     89                          13                          100   88    42   4.5   1   1   0
  ATCP, 2012       100                     100                         81                          100   92    17   6.5   2   0   0
  NCCEP, 2019      100                     78                          56                          100   79    33   5.0   1   1   0
  PHECC, 2018      100                     100                         77                          100   100   8    6.0   2   0   0
  AVCP, 2018       100                     100                         75                          100   88    25   5.5   2   0   0
  MIEMS, 2014      100                     100                         81                          100   92    33   5.0   1   1   0
  IIRPM, 2015      100                     100                         67                          100   88    33   4.5   0   1   1
  NMPHT, 2018      89                      72                          13                          100   79    42   4.5   1   1   0
  NAEMSP, 2014     94                      100                         83                          100   96    33   6.5   2   0   0
  NICE, 2016       100                     100                         81                          100   96    33   6.5   2   0   0

Domain 1: Aim and Scope; Domain 2: Stakeholder involvement; Domain 3: Rigor of development; Domain 4: Clarity of presentation; Domain 5: Applicability; Domain 6: Editorial independence.

![Flow diagram of the present review](aaem-7-e55-g001){#F1}

**Quality assessment of the articles**

Quality assessment of the articles was performed using AGREE II guideline ([@B9]). In order to determine the agreement between the two reviewers, evaluation of Inter-rater reliability in quality assessment of the articles was done. Disagreements were resolved through discussion with a third researcher.

Results
=======

**Demographic characteristics of the articles**

Our search in databases and non-indexed guidelines came up with 5988 records. Excluding duplicate records, 4998 articles were found. Reading their titles and abstracts and the full texts of these guidelines, and according to inclusion and exclusion criteria, 12 guidelines for pre-hospital pain management were included in this review ([@B10]-[@B21]). These guidelines were updated between 2012 and 2019 ([Figure 1](#F1){ref-type="fig"}). Four guidelines were designed for managing pain in trauma patients ([@B10], [@B12], [@B20], [@B21]) and the other guidelines were developed for all conditions accompanying pain. All of the 12 included guidelines provided instructions on managing pain in adults, while 10 guidelines ([@B11]-[@B20]) reported pain management methods in children. [Table 1](#T2){ref-type="table"} demonstrates demographic characteristics of these guidelines.

All of the above-mentioned guidelines emphasize on a standard method of pain evaluation. Suggested tools in these guidelines for adults included numeric analog scale (NRS) and visual analog scale (VAS), and for children included The Face, Legs, Activity, Cry, CONSOL ability scale (FLACC) or Children\'s Hospital of Eastern Ontario Pain Scale (CHEOPS scale), Faces Pain Scale (FPS) scale, FPS-revised, Wong Baker scale and NRS.

**Pain management in adults**

As mentioned previously, pain management in adults was reported in all of the 12 studies. Different medications are suggested in these guidelines which include: fentanyl, morphine, ketamine, paracetamol, midazolam, nitric oxide, ketorolac, ibuprofen, methoxyflurane, nonsteroidal anti-inflammatory drugs, codeine, tramadol and aspirin. Medication protocols are modified in these guidelines based on the severity of pain.

***Pre-hospital management of mild pain in adults***

Five studies accurately proposed protocols for pre-hospital management of mild pain. Mild pain is described as a severity less than 4, on a 0-10 pain scale. Based on the guidelines included in the present systematic review, management of a patient with mild or endurable pain is prescribing oral paracetamol (1000mg or 15mg/kg). One guideline recommends that if a patient has weighs less than 60 kg, or is older than 60 or is malnourished, the suggested dose for paracetamol should be reduced to half. Only one guideline suggests administration of ketorolac (30mg, IV/IO or 60 mg, IM) instead of paracetamol in relieving mild pain. This guideline proposes administration of nitric oxide in 50:50 dosage as an alternative treatment.

***Pre-hospital management of moderate pain in adults***

10 guidelines proposed instructions for pre-hospital management of moderate pain. Moderate pain is described as a severity between 4 and 6 on a 0-10 pain scale. Based on the guidelines included in the present systematic review, management of a patient with moderate pain is mainly done by prescribing morphine and fentanyl. However, two guidelines ([@B15], [@B18]) recommend administering paracetamol 1000 mg instead. Using morphine in moderate pain management is mentioned unfavorable in NAEN guideline as well. Rather, it is recommended to use fentanyl (1-2 g/kg) or paracetamol (1000 mg) IV in 5 minutes (or as oral agent). Assuming that the patient is hypovolemic or in shock, this guideline recommends using ketamine (0.25 mg/kg) and midazolam (1 mg) for pain alleviation ([@B10]). NICE guideline, recommends using morphine as the first line treatment and ketamine as the second line ([@B21]). This guideline does not clarify the dosage and route of administration ([Table 2](#T3){ref-type="table"}).

Intravenous paracetamol (five guidelines), ketamine (three guidelines), ketorolac (one guideline) and nonsteroidal anti-inflammatory drugs (one guideline) are other recommended options for adults' pain management in prehospital conditions. Although, one guideline ([@B20]) prohibits using nonsteroidal anti-inflammatory drugs in management of Trauma patients ([Table 2](#T4){ref-type="table"}).

***Pre-hospital management of severe pain in adults***

12 guidelines proposed instructions on pre-hospital management of severe pain. Severe pain is described as a severity of more than 6 on a 0-10 pain scale. Based on the guidelines included in the present systematic review, prescribing morphine and fentanyl is the first line of treatment in pre-hospital managing severe pain. Nevertheless, guidelines show some controversy. NAEN guideline 2014 suggests using fentanyl (1-2 g/kg) infused with paracetamol (1000 mg). This guideline does not recommend using morphine. Furthermore, NAEN guideline indicates that using ketamine (25 mg/kg IV) infused with midazolam (1mg, IV) and paracetamol (1000 mg IV) (10) is preferable in cases with evidence of hypovolemia or insecure airways ([@B10]). Administration of ketamine is recommended in four other protocols ([@B11], [@B15], [@B16], [@B20]) ([Table 2](#T5){ref-type="table"}).

Intravenous paracetamol (two guidelines), nitric oxide (three guidelines), ibuprofen (three guidelines), ketorolac (two guidelines), methoxyflurane (three guidelines), non-steroidal anti-inflammatory drugs (one guideline) and diamorphine (one guideline) are alternative options in pre-hospital management of severe pain in adults. One guideline suggested prescription of codeine and tramadol while another one recommended aspirin prescription ([Table 2](#T3){ref-type="table"}).

**Pain management in children (under 14 years)**

As mentioned, pre-hospital pain management in children was reported in 10 of the included studies. In these guidelines, different medications were proposed, which included morphine, fentanyl, ketamine, paracetamol, midazolam, nitric oxide, ketorolac, ibuprofen, methoxyflurane, codeine, tramadol and hydromorphone. In these guidelines, instructions for using medications were different according to the severity of pain.

***Pre-hospital management of mild pain in children***

Four guidelines precisely proposed instructions on pre-hospital management of mild pain in children. According to the guidelines, control and management of pain in a child who is having mild pain include appeasing the child's pain or at most prescribing paracetamol in a dose of 10-20mg/kg and ibuprofen in a dose of 4-10 mg/kg ([Table 3](#T6){ref-type="table"}).

***Pre-hospital management of moderate pain in children***

Eight guidelines provided advice on pre-hospital management of moderate pain. Different medications are recommended for controlling and managing moderate pain in children. Six of these guidelines suggest using intravenous (IV), intranasal (IN) or intra-osseous (IO) fentanyl. Also, five guidelines proposed using paracetamol with a 15 mg/kg dosage, and four guidelines referred to morphine as a treatment option ([Table 3](#T7){ref-type="table"}). It is worth mentioning that only one guideline recommends intranasal ketamine in 0.5 mg/kg dosage for managing moderate pain ([@B20]).

Other recommended drugs in moderate pain management in children include methoxyflurane (three guidelines), ketorolac (two guidelines), nitric oxide (two guidelines), ibuprofen (two guidelines), and codeine and tramadol (one guideline) ([Table 3](#T7){ref-type="table"}).

***Pre-hospital management of severe pain in children***

10 guidelines provided instructions on pre-hospital management of severe pain in children. The first line of treatment in pre-hospital management of severe pain in children is prescribing morphine and fentanyl.

Nine guidelines suggested using fentanyl (1-2 μg/kg IV/IN/IO or 25-50 μg IN only) for severe pain management in children. Also, eight guidelines recommended morphine (0.05-0.1 mg/kg) as a treatment option. Three guidelines proposed intravenous, intranasal or intra-osseous ketamine as another option for pain management. Furthermore, a guideline suggested using intravenous ketamine (0.25 mg/kg) only when there is a severe trauma pain in the limbs, which is not responding to opioids ([@B16]).

Paracetamol (one protocol), nitric oxide (one protocol only after consultation), ketorolac (two protocols), methoxyflurane (two protocols) and hydromorphone (one protocol) are other drugs recommended for strict pain management in children ([Table 3](#T8){ref-type="table"}).

**Quality Control of Guidelines**

The overall score of the included guidelines varied from 4.5 to 6.5. Aim and scope domain rating of the guidelines varied from 88% to 100%, stakeholder involvement domain varied from 72% to 100%, rigor of development domain varied from 12% to 81%, applicability domain varied from 79% to 100% and editorial independence varied from 8% to 50%. In the domain of clarity of presentation, the score of all studies was 100% ([Table 4](#T9){ref-type="table"}).

Discussion
==========

The current systematic review summarized the existing evidence on pre-hospital pain management, evaluating available guidelines and protocols. These guidelines provided instructions based on age groups (adults and children) and pain severity. The majority of guidelines recommended paracetamol as the medication of choice for management of mild pain in adults and children. For management of moderate to severe pain in pre-hospital setting, fentanyl and morphine are the first line choices. Fentanyl is the first line treatment for children.

Although, some of the guidelines referred to ketamine as an alternative treatment for pain management, it seems that ketamine is still not the first line treatment in these conditions. However, it appears that ketamine should be prescribed instead of fentanyl if the patient is hypovolemic or the airway is not secure. Overall, there is no strong evidence supporting the usage of ketamine in pain management.

Only two guidelines reported levels of evidence in detail. All of the other guidelines depicted a description regarding how the guideline was achieved and levels of evidence. Indeed, levels of evidence presented in each guideline varied from the others. In general, levels of evidence presented for using fentanyl and morphine in pain management is moderate to high. In case of using ketamine, one guideline has referred to reported evidence as poor, and the other articles disregarded the usage of ketamine.

Overall, management of mild pain was mentioned as opioid-free in guidelines, while almost all the guidelines (except for two protocols in moderate pain management section) referred to fentanyl or morphine as the first line treatments for moderate to severe pain management. The two mentioned guidelines regarding management of moderate pain ([@B15], [@B18]) did not recommend using fentanyl and morphine and suggested using paracetamol with 1000 mg dosage instead.

The majority of the guidelines provided single-drug protocols. Only in special circumstances, such as shock, hypovolemia and unsecure airways, multidrug protocols are suggested. In this regard, the NAEN, 2014 guideline recommended that if a patient is hypovolemic or has no secure airways, ketamine in 0.25 mg/kg dosage with midazolam in 1 mg dosage should be administered.

Conclusion
==========

The present systematic review has summarized the current evidence in pre-hospital pain management for the first time via investigation of guidelines and protocols concerning the matter. These guidelines presented instructions in age (adults and children) and pain severity categories. Based on the obtained evidence, most of the guidelines recommend paracetamol as the treatment of choice for mild pain in both children and adults. For moderate and severe pain management, fentanyl and morphine are suggested medications for both adults and children, between these two medications, fentanyl is the treatment of choice for children. In conclusion, opioid-free protocols still have no place in pre-hospital management of moderate to severe pain.
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